British drug discovery company in London, founded in 2021 as a sister company of DeepMind within Alphabet and led by Demis Hassabis, which applies artificial intelligence to the design of medicines. Builds on the AlphaFold protein structure models to predict how molecules interact with their targets, runs its own discovery programmes in oncology and immunology, and works with Eli Lilly and Novartis on partnered discovery projects.
No comments available.
Leave your rating & comment